Cargando…
Potential of anti-inflammatory treatment for cystic fibrosis lung disease
Cystic fibrosis (CF) is the most common life-shortening genetic disorder in Caucasians. With improved diagnosis and treatment, survival has steadily increased. Unfortunately, the overwhelming majority of patients still die from respiratory failure caused by structural damage resulting from airway ob...
Autores principales: | Taylor-Cousar, Jennifer L, Von Kessel, Kelsey A, Young, Robert, Nichols, David P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3218732/ https://www.ncbi.nlm.nih.gov/pubmed/22096358 |
Ejemplares similares
-
The combination of tezacaftor and ivacaftor in the treatment of patients with cystic fibrosis: clinical evidence and future prospects in cystic fibrosis therapy
por: Lommatzsch, Sherstin T., et al.
Publicado: (2019) -
Impact of CFTR modulator use on outcomes in people with severe cystic fibrosis lung disease
por: Shteinberg, Michal, et al.
Publicado: (2020) -
Management of pregnancy in cystic fibrosis
por: Montemayor, Kristina, et al.
Publicado: (2022) -
CFTR Modulators: Impact on Fertility, Pregnancy, and Lactation in Women with Cystic Fibrosis
por: Taylor-Cousar, Jennifer L.
Publicado: (2020) -
Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity
por: Taylor-Cousar, Jennifer L., et al.
Publicado: (2009)